Exosome treatments are often advertised as though the evidence were settled. In April a review collecting the studies published so far appeared in a journal. Reading it in full, the weight of evidence differed sharply by indication. Some had measured figures; others had a record of three patients.
Exosomes are very small vesicles released by cells. They carry signalling molecules such as nucleic acids and proteins, wrapped in a lipid membrane. That membrane binds readily to a target cell and delivers what is inside.
Microneedling creates microchannels in the skin with fine needles. Deliberate small injury prompts new collagen and elastin during repair. Exosomes applied topically do not enter the skin, which is why the two are used together.
The authors searched PubMed, Embase and Scopus through June 2025. After removing duplicates, 256 papers remained; ten met the criteria and were quality-assessed. Two scoring below 70% were excluded, leaving eight studies in the review.
Across all eight, 171 participants. Three studies came from Korea, one each from the United States, Italy, Greece and China, and one did not state a country.
| Indication | Size | Design |
|---|---|---|
| Male pattern hair loss | 30 | 24-week observation |
| Skin ageing | 28 · 15 | Split-face comparison |
| Melasma | 20 · 60 | Observational · four-group comparison |
| Pigmentation | 12 | Uncontrolled observation |
| Acne · scars · pigmentation | 3 each | Case report |
The table makes the point: the weight of evidence differs by indication. Skin ageing was studied by treating one half of the face and comparing, which is a relatively reliable design. Acne and pores are records of three patients.
Skin ageing has the strongest support. In 28 participants treated on one side of the face and assessed at 12 weeks, wrinkle roughness fell 12–14% on the treated side versus about 7% untreated. Elasticity rose 11.3% on the treated side while falling 3.3% on the untreated side. The difference was statistically significant.
Melasma and pigmentation also produced figures. In 20 participants, 88.9% moved from moderate to mild and 10% were unchanged. In a separate study of 12, surface pigmentation fell from 39.8% to 26.8% and deep pigmentation from 45.3% to 29.4% at 12 weeks.
Hair loss changed little. In 30 participants followed for 24 weeks, hair density rose from 158.03 to 166.14 per square centimetre: eight hairs over 24 weeks. On photographic assessment at 24 weeks, 37.93% were unchanged and 10.34% slightly worse.
Acne and pores rest on case reports of three patients each. On the acne side, two months after a single session severity fell from 3.34 to 1.34 and the pigmentation score from 12 to 6.67, with satisfaction at 8.6 out of 10. The numbers look good, but there were three patients.
Two out of three improving is 67%: the same figure as 67 out of 100. The reliability is not remotely the same. With three people the result can be chance, or the group can happen to contain people who would have improved anyway.
Follow-up was short. The two melasma studies ended at 12 weeks and at four to five months, with nothing at six months or a year. The review notes this, stating that whether the effect persists after the final session is unknown.
In all eight studies, no patient discontinued because of side effects. In two, symptoms resolved within a week; in one, within 24 to 72 hours. Three reported resolution without giving a period.
Reported symptoms were stinging, mild redness, swelling, pinpoint bleeding, burning, itching and pain during the procedure. One study reported a single case of increased sensitivity and two cases of persistent red patches.
This is short-term safety. Follow-up was too short to say whether problems emerge later.
The question is not whether evidence exists. It does: the review was peer-reviewed and pre-registered on PROSPERO, and skin ageing and pigmentation showed statistically significant differences in controlled comparisons.
The issue is that the weight of evidence differs by indication, and advertising flattens that difference. Figures from skin ageing get used to speak for pores and acne as well.
| If you are told | Against the review |
|---|---|
| Proven for every skin concern | Not supported. Evidence differs by indication |
| Texture and pigmentation showed differences in controlled studies | Accurate |
| Good for hair loss too | Eight hairs per square centimetre over 24 weeks |
| Definitely works on pores | A case report of three patients |
The authors declared no conflict of interest.
One usable standard comes out of this review: ask which indication the evidence is for.
Texture and pigmentation showed differences in controlled comparison. Pores and acne are records of three patients. Advertising tends to erase that distinction.
Asking "which study is that result from?" in consultation brings the difference out.
It depends on the indication. Texture and pigmentation showed differences in controlled comparison. Pores and acne rest on observations of three patients each.
In 30 participants over 24 weeks, hair density rose by about eight per square centimetre. In the same study 37.93% were unchanged.
No participant discontinued because of side effects across the eight studies, but follow-up was short, so long-term safety is not established.
Exosomes applied topically do not penetrate the skin. Microneedling provides the channel.
